Century Aluminum Co. is engaged in the production of primary aluminum in the U.S. and Iceland. The company produces standard grade and value-added primary aluminum products as well as carbon products such as anodes and cathodes. It operates through one reportable segment, Primary Aluminum. It operates 3 U.S. aluminum smelters in Hawesville, Robards(Sebree), Mt. Holly, and one smelter in Grundartangi, Iceland. Hawesville is the company's biggest U.S. smelter and the largest producer of high purity primary aluminum in N. America. Sebree is a primary aluminum reduction facility that makes standard-grade aluminum which is cast into several products including billet, foundry and slab. The company is expanding its Sebree smelter. Mt. Holly is a primary aluminum reduction facility which makes standard-grade aluminum that is cast into tee bars and several value-added products. The company entered into an agreement with Santee Cooper that will enable the Goose Creek, SC plant to continue operating at half capacity....
+See More2017-12-01 06:30:00 Friday ET

Dr Kai-Fu Lee praises China as the next epicenter of artificial intelligence, smart data analysis, and robotic automation. With prior IT careers at Apple, M
2025-01-22 08:35:08 Wednesday ET

President Donald Trump blames China for the long prevalent U.S. trade deficits and several other social and economic deficiencies. In recent years, Pres
2019-10-11 13:40:00 Friday ET

Apple CEO Tim Cook maintains a frugal low-key lifestyle. With $625 million public wealth, Cook leads the $1 trillion tech titan Apple in the post-Jobs era.
2018-07-11 09:39:00 Wednesday ET

In recent times, the Trump administration sees the sweet state of U.S. economic expansion as of early-July 2018. The latest CNBC All-America Economic Survey
2019-10-05 07:27:00 Saturday ET

Treasury Secretary Steven Mnuchin indicates that there is a good conceptual trade agreement between China and the U.S. in regard to intellectual property pr
2026-10-31 12:38:00 Saturday ET

Today tech titans and billionaires continue to reshape global pharmaceutical investments for both better healthspan and longer lifespan. We discuss, desc